Drugs

What are researchers making of ‘nonresponders’ to those trying to take Wegovy or Mounjaro for obesity?

Website is a cross-Canada collaboration of researchers.

The Canadian Headache Society has issued updated (2024) guidelines for the prevention of episodic and chronic migraine.

New report from GreenShield highlights trends in prescription drug use trends and pharmacist prescribing based on data from 2023 member claims.

Canadian Headache Society updates the migraine prevention guidelines, incorporating newer therapies and adding guidance on preventing chronic migraine.

A new study from Korea may pose more questions than it answers.

Methadone or buprenorphine should be considered as standard first-line treatment for opioid use disorder, with slow-release oral morphine as a second-line treatment option.

A review of new launches, new indications, new dosage forms and Health Canada advisories.